×
About 3,997 results

ALLMedicine™ Bacterial Pneumonia Center

Research & Reviews  1,679 results

An Overview of Cilastatin + Imipenem + Relebactam as a Therapeutic Option for Hospital-...
https://doi.org/10.1080/14656566.2021.1939680
Expert Opinion on Pharmacotherapy; Sellarès-Nadal J, Eremiev S et. al.

Jun 14th, 2021 - Introduction: Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) are prevalent nosocomial infections with a worrisomely increasing prevalence of multidrug-resistant causative organisms, including those with resistance to c...

Heparin-based blood purification attenuates organ injury in baboons with S. pneumoniae ...
https://doi.org/10.1152/ajplung.00337.2020
American Journal of Physiology. Lung Cellular and Molecul... Chen L, Kraft BD et. al.

Jun 9th, 2021 - Bacterial pneumonia is a major cause of morbidity and mortality worldwide despite the use of antibiotics, and novel therapies are urgently needed. Building on previous work, we aimed to 1) develop a baboon model of severe pneumococcal pneumonia an...

Outcomes of Adult Patients in the Intensive Care Unit with Pseudomonas aeruginosa Pneum...
https://doi.org/10.1002/phar.2600
Pharmacotherapy Lodise TP, Puzniak LA et. al.

Jun 7th, 2021 - The most commonly prescribed antibiotics for patients with hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) due to Pseudomonas aeruginosa are the conventional anti-pseudomonal β-lactams (APBLs) (i.e...

Reducing the use of empiric antibiotic therapy in COVID-19 on hospital admission.
https://doi.org/10.1186/s12879-021-06219-z 10.1177/2042098614554919 10.2147/IDR.S65928 10.1016/j.cmi.2015.06.015 10.1093/jac/dkw441 10.1001/archinternmed.2012.1690 10.1093/intqhc/mzq077 10.1186/s12879-016-1426-1 10.4212/cjhp.v67i1.1317 10.1093/cid/cis242 10.3810/hp.2013.08.1063 10.1001/jama.283.6.749 10.1093/jac/dky021 10.1001/jama.2020.9611
BMC Infectious Diseases; Pettit NN, Nguyen CT et. al.

Jun 3rd, 2021 - Empiric antibiotics for community acquired bacterial pneumonia (CABP) are often prescribed to patients with COVID-19, despite a low reported incidence of co-infections. Stewardship interventions targeted at facilitating appropriate antibiotic pres...

Lung-resident memory B cells protect against bacterial pneumonia.
https://doi.org/10.1172/JCI141810
The Journal of Clinical Investigation; Barker KA, Etesami NS et. al.

Jun 1st, 2021 - Lung-resident memory B cells (BRM cells) are elicited after influenza infections of mice, but connections to other pathogens and hosts - as well as their functional significance - have yet to be determined. We postulate that BRM cells are core com...

see more →

Guidelines  7 results

Shared Decision-Making for Administering PCV13 in Older Adults
https://www.aafp.org/afp/2020/0201/p134.html
American Family Physician; Shah AA,et al

Jan 31st, 2020 - Streptococcus pneumoniae infection, the most common cause of bacterial pneumonia, leads to significant morbidity and mortality in older people. With the addition of the pneumococcal conjugate vaccine to childhood immunization schedules in 2000, he...

Melinta Therapeutics Announces U.S. FDA Approval of Supplemental New Drug Application for BAXDELA® (delafloxacin) for the Treatment of Community-Acquired Bacterial Pneumonia (CABP)
http://ir.melinta.com/news-releases/news-release-details/melinta-therapeutics-announces-us-fda-approval-supplemental-new

Oct 23rd, 2019 - Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to treat serious bacterial infections, today announced the U.S. Food and Drug Administration (FDA) has appr...

Improving Conduct and Feasibility of Clinical Trials to Evaluate Antibacterial Drugs to...
https://doi.org/10.1093/cid/ciw258
Clinical Infectious Diseases : an Official Publication Of... Knirsch C, Alemayehu D et. al.

Aug 2nd, 2016 - The etiology of hospital-acquired or ventilator-associated bacterial pneumonia (HABP/VABP) is often multidrug-resistant infections. The evaluation of new antibacterial drugs for efficacy in this population is important, as many antibacterial drugs...

Streamlining Safety Data Collection in Hospital-Acquired Bacterial Pneumonia and Ventil...
https://doi.org/10.1093/cid/ciw316
Clinical Infectious Diseases : an Official Publication Of... Donnelly H, Alemayehu D et. al.

Aug 2nd, 2016 - Resistant bacteria are one of the leading causes of hospital-acquired/ventilator-associated bacterial pneumonia (HABP/VABP). HABP/VABP trials are complex and difficult to conduct due to the large number of medical procedures, adverse events, and c...

XENLETA™ (lefamulin) Website for Healthcare Professionals
https://www.xenleta.com/

community-acquired bacterial pneumonia See XENLETA™ (lefamulin) clinical trial results and product attributes

see more →

Drugs  151 results see all →

Clinicaltrials.gov  1,961 results

An Overview of Cilastatin + Imipenem + Relebactam as a Therapeutic Option for Hospital-...
https://doi.org/10.1080/14656566.2021.1939680
Expert Opinion on Pharmacotherapy; Sellarès-Nadal J, Eremiev S et. al.

Jun 14th, 2021 - Introduction: Hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) are prevalent nosocomial infections with a worrisomely increasing prevalence of multidrug-resistant causative organisms, including those with resistance to c...

Heparin-based blood purification attenuates organ injury in baboons with S. pneumoniae ...
https://doi.org/10.1152/ajplung.00337.2020
American Journal of Physiology. Lung Cellular and Molecul... Chen L, Kraft BD et. al.

Jun 9th, 2021 - Bacterial pneumonia is a major cause of morbidity and mortality worldwide despite the use of antibiotics, and novel therapies are urgently needed. Building on previous work, we aimed to 1) develop a baboon model of severe pneumococcal pneumonia an...

Teflaro - ceftaroline fosamil powder, for solution-Allergan, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3ecde48b-75a2-4beb-9999-369f3f61bb8a

Jun 8th, 2021 - Teflaro is a cephalosporin antibacterial indicated in adult and pediatric patients for the treatment of the following infection caused by designated susceptible bacteria: Acute bacterial skin and skin structure infections (ABSSSI) in adult and ped...

Outcomes of Adult Patients in the Intensive Care Unit with Pseudomonas aeruginosa Pneum...
https://doi.org/10.1002/phar.2600
Pharmacotherapy Lodise TP, Puzniak LA et. al.

Jun 7th, 2021 - The most commonly prescribed antibiotics for patients with hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) due to Pseudomonas aeruginosa are the conventional anti-pseudomonal β-lactams (APBLs) (i.e...

Reducing the use of empiric antibiotic therapy in COVID-19 on hospital admission.
https://doi.org/10.1186/s12879-021-06219-z 10.1177/2042098614554919 10.2147/IDR.S65928 10.1016/j.cmi.2015.06.015 10.1093/jac/dkw441 10.1001/archinternmed.2012.1690 10.1093/intqhc/mzq077 10.1186/s12879-016-1426-1 10.4212/cjhp.v67i1.1317 10.1093/cid/cis242 10.3810/hp.2013.08.1063 10.1001/jama.283.6.749 10.1093/jac/dky021 10.1001/jama.2020.9611
BMC Infectious Diseases; Pettit NN, Nguyen CT et. al.

Jun 3rd, 2021 - Empiric antibiotics for community acquired bacterial pneumonia (CABP) are often prescribed to patients with COVID-19, despite a low reported incidence of co-infections. Stewardship interventions targeted at facilitating appropriate antibiotic pres...

see more →

News  197 results

Online COVID-19 Symptom Checkers May Not Catch Severe Illnesses
https://www.medscape.com/viewarticle/947253

Mar 11th, 2021 - NEW YORK (Reuters Health) - Digital COVID-19 symptom checkers in the U.S. and the U.K. may fail to identify severe COVID-19 and other serious illnesses such as bacterial pneumonia or sepsis, according to a group of public-health researchers. The o...

How the COVID Pandemic May End: Lessons From the 1918 Flu
https://www.medscape.com/viewarticle/940788

Nov 11th, 2020 - Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The Spanish flu hit in the fall of 1918; a second surge occurred from January to April 1919, and a smaller one followed in the winter of 1920. Forty million peop...

As COVID-19 Cases Spike, Pneumonia Vaccine Demand Rockets and Europe Runs Low
https://www.staging.medscape.com/viewarticle/939667

Oct 25th, 2020 - MILAN/FRANKFURT/NEW YORK (Reuters) - As COVID-19 infections rise, people seeking to avoid one lung disease compounding another are queuing up to get inoculated against bacterial pneumonia, causing shortages of a Merck & Co vaccine in parts of Euro...

As COVID-19 Cases Spike, Pneumonia Vaccine Demand Rockets and Europe Runs Low
https://www.medscape.com/viewarticle/939667

Oct 25th, 2020 - MILAN/FRANKFURT/NEW YORK (Reuters) - As COVID-19 infections rise, people seeking to avoid one lung disease compounding another are queuing up to get inoculated against bacterial pneumonia, causing shortages of a Merck & Co vaccine in parts of Euro...

Fast Five Quiz: Pneumonia Key Aspects
https://reference.medscape.com/viewarticle/922410_2

Mar 22nd, 2020 - Physical examination findings may vary depending on the type of organism, severity of infection, coexisting host factors, and presence of complications. Signs of bacterial pneumonia may include the following: Hyperthermia (fever, typically > 38°C)...

see more →

Patient Education  2 results see all →